Michael Houghton
Director/Board Member at ASSEMBLY BIOSCIENCES, INC.
Net worth: - $ as of 29/04/2024
Profile
Michael Houghton is currently the Chairman-Virology at the University of Alberta.
He is also the Director at the Li Ka Shing Institute of Virology.
In addition, he serves as an Independent Director at Assembly Biosciences, Inc. and as a Director at Achlys, Inc., Prophysis, Inc., Aurora Vaccines, Inc., Heka Therapeutics, Inc., and Egerio, Inc. Previously, Dr. Houghton held the position of Vice President-Hepatitis C & Virology Research at Novartis Vaccines & Diagnostics, Inc. He also served as the Chief Scientific Officer at Epiphany Biosciences, Inc. from 2007 to 2009.
Prior to that, he was a Professor at the University of Alberta.
Dr. Houghton completed his undergraduate degree at the University of East Anglia and obtained his doctorate from King's College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2024 | 0 ( -.--% ) | - $ | 29/04/2024 |
Michael Houghton active positions
| Companies | Position | Start |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Director/Board Member | 18/07/2021 |
Li Ka Shing Institute of Virology
 Li Ka Shing Institute of Virology Miscellaneous Commercial ServicesCommercial Services Li Ka Shing Institute of Virology supports discoveries in vaccines, treatments, and diagnostic tests for viral diseases affecting humans. Its technology platforms include ribonucleic acid interface screening core, flow cytometry, and microscopy. The company was founded in April 2010 and is headquartered in Edmonton, Canada. | Director/Board Member | - |
| University of Alberta | Corporate Officer/Principal | 31/12/2009 |
| Achlys, Inc. | Director/Board Member | - |
Former positions of Michael Houghton
| Companies | Position | End |
|---|---|---|
Epiphany Biosciences, Inc.
 Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Epiphany Biosciences, Inc. develops therapeutic products and diagnostic technologies that treat and prevent the spread of pathogenic viruses. The firm develops therapeutics to prevent spread of varicella zoster virus (VZV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV). The company was founded by David C Myles, Robert Charles Gallo, Harold E Selick and Frederick Volinsky in 2001 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 31/12/2008 |
| University of Alberta | Corporate Officer/Principal | - |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Training of Michael Houghton
| University of East Anglia | Undergraduate Degree |
| King's College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Epiphany Biosciences, Inc.
Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Epiphany Biosciences, Inc. develops therapeutic products and diagnostic technologies that treat and prevent the spread of pathogenic viruses. The firm develops therapeutics to prevent spread of varicella zoster virus (VZV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV). The company was founded by David C Myles, Robert Charles Gallo, Harold E Selick and Frederick Volinsky in 2001 and is headquartered in San Francisco, CA. | Health Technology |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
Li Ka Shing Institute of Virology
Li Ka Shing Institute of Virology Miscellaneous Commercial ServicesCommercial Services Li Ka Shing Institute of Virology supports discoveries in vaccines, treatments, and diagnostic tests for viral diseases affecting humans. Its technology platforms include ribonucleic acid interface screening core, flow cytometry, and microscopy. The company was founded in April 2010 and is headquartered in Edmonton, Canada. | Commercial Services |
| Achlys, Inc. |
- Stock Market
- Insiders
- Michael Houghton
